CHICAGO — A new study shows for the first time that drug therapy can reduce major heart failure clinical outcomes in patients with heart failure and...
LONDON — It may not be recommended for patients with pre-existing conditions. Myocardial infarction The researchers caution that discontinuing long-term beta-blocker therapy may preserve left ventricular...
ATLANTA — Weekly shots glucagonβ-like peptide (GLP-1) receptor agonist Semaglutide (Wegovy, Ozempic), reduces symptoms in patients with: heart failure Using preserved ejection fraction (HFpEF); obesityDiabetes is...
Editor’s Note: For the latest lengthy COVID-19 news and guidance, please visit Medscape’s Long COVID Resource Center. hyperbaric oxygen therapy (HBOT) Increased markers of cardiac function...
The results of a large British trial of more than 200,000 women followed for a median of 16 years turned out to be negative. Researchers Ovarian...
Recent Comments